These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 731022)

  • 1. e-Antigen: a link between immune response and infectivity in hepatitis B?
    Turner GC; Green HT; Blundell VD
    J Hyg (Lond); 1978 Dec; 81(3):405-14. PubMed ID: 731022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full and empty Dane particles in chronic hepatitis B virus infection: relation to hepatitis B e antigen and presence of liver damage.
    Alberti A; Diana S; Scullard GH; Eddleston WF; Williams R
    Gastroenterology; 1978 Nov; 75(5):869-74. PubMed ID: 700329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surface antigen (HBsAg) and core antibody (anti-HBc) in chronic uremia during periodic hemodialysis treatment of hepatitis B patients. Correlation with viral replication markers (HBeAg and DNA polymerase activity)].
    Buongiorno R; Dentico P; Santantonio T; Frappampina V; Spinelli A; Amato M; Pastore G
    Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2076-82. PubMed ID: 7459119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infectivity markers in HBsAg chronic carriers and intrafamilial spread of hepatitis B virus infection.
    Pastore G; Dentico P; Angarano G; Lapedota E; Schiraldi O
    Hepatogastroenterology; 1981 Feb; 28(1):20-2. PubMed ID: 7216135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between the detection of e antigen or antibody and electron microscopic pattern of hepatitis B surface antigen (HBsAg) associated particles in the serum of HBsAg carriers.
    Trepo C; Bird RG; Zuckerman AJ
    J Clin Pathol; 1977 Mar; 30(3):216-20. PubMed ID: 403201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.
    Chadwick RG; Bassendine MF; Crawford EM; Thomas HC; Sherlock S
    Br Med J; 1978 Aug; 2(6136):531-3. PubMed ID: 698557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of e antigen to infectivity of hBsAg-positive inoculations among medical personnel.
    Lancet; 1976 Sep; 1(7984):492-4. PubMed ID: 74462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated immune response to liver tissue antigen and hepatitis B surface antigen after infection with hepatitis B virus in humans.
    Tiku ML; Beutner KR; Tiku K; Ogra PL
    J Infect Dis; 1978 Nov; 138(5):587-96. PubMed ID: 712116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The course of hepatitis B in 9 children who became positive for viral surface antigen HBsAg in spite of vaccination].
    del Canho R; Grosheide PM; Heijtink RA; Schalm SW
    Ned Tijdschr Geneeskd; 1993 Dec; 137(50):2599-603. PubMed ID: 8277987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dane particles and associated DNA-polymerase activity in saliva of chronic hepatitis B carriers.
    Macaya G; Visoná KA; Villarejos VM
    J Med Virol; 1979; 4(4):291-301. PubMed ID: 541682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ways for the evaluation of the infectivity of HBS-Ag positive subjects].
    Stalder GA
    Schweiz Med Wochenschr; 1977 May; 107(18):614-7. PubMed ID: 867006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune response to HBsAg, HBcAg and e-antigen in patients with acute hepatitis and HBsAg carriers with and without liver diseases].
    Meyer zum Büschenfelde KH; Arnold W; Knolle J; Hess G
    Z Gastroenterol; 1976 May; 14(3):365-77. PubMed ID: 969780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoelectron microscopic observation of hepatitis B surface antigen on the surface of liver cells from patients with hepatitis B virus infection.
    Yamada G; Takahashi T; Mizuno M; Sakamoto Y; Kaga K; Kobayashi T; Nagashima H
    Acta Med Okayama; 1980 Jun; 34(3):175-87. PubMed ID: 6447986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HBeAg and Anti-HBe in various groups of acute hepatitis patients and carriers of HBsAg].
    Zanetti AR
    Boll Ist Sieroter Milan; 1977 Mar; 56(1):74-8. PubMed ID: 861075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus (HBV) infections in turtles.
    Lee WY; Yoo NC
    Yonsei Med J; 1989; 30(2):144-50. PubMed ID: 2800564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B e antigen, DNA polymerase activity, and infection of household contacts with hepatitis B virus.
    Perrillo RP; Gelb L; Campbell C; Wellinghoff W; Ellis FR; Overby L; Aach RD
    Gastroenterology; 1979 Jun; 76(6):1319-25. PubMed ID: 437428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study.
    Bassendine MF; Chadwick RG; Salmeron J; Shipton U; Thomas HC; Sherlock S
    Gastroenterology; 1981 May; 80(5 pt 1):1016-22. PubMed ID: 7009310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance.
    Ghisetti V; Marzano A; Zamboni F; Barbui A; Franchello A; Gaia S; Marchiaro G; Salizzoni M; Rizzetto M
    Liver Transpl; 2004 Mar; 10(3):356-62. PubMed ID: 15004761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation in European patients with the hepatitis B surface antigen.
    Samuel D; Muller R; Alexander G; Fassati L; Ducot B; Benhamou JP; Bismuth H
    N Engl J Med; 1993 Dec; 329(25):1842-7. PubMed ID: 8247035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.